CXCL9 and neoplasm: In this study, IL11 mutein screened by Lee et al. was verified for its therapeutic effect in vivo [26], which was proved to remarkably increase CXCL9 and MHC-I molecules, thus increasing T cell infiltration tissues and antigen presentation in tumor.